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AbsTrACT
background One- size- fits- all interventions reduce 
chronic low back pain (CLBP) a small amount. An 
individualised intervention called cognitive functional 
therapy (CFT) was superior for CLBP compared with 
manual therapy and exercise in one randomised 
controlled trial (RCT). However, systematic reviews 
show group interventions are as effective as one- to- 
one interventions for musculoskeletal pain. This RCT 
investigated whether a physiotherapist- delivered 
individualised intervention (CFT) was more effective 
than physiotherapist- delivered group- based exercise and 
education for individuals with CLBP.
Methods 206 adults with CLBP were randomised 
to either CFT (n=106) or group- based exercise 
and education (n=100). The length of the CFT 
intervention varied according to the clinical progression 
of participants (mean=5 treatments). The group 
intervention consisted of up to 6 classes (mean=4 
classes) over 6–8 weeks. Primary outcomes were 
disability and pain intensity in the past week at 6 months 
and 12months postrandomisation. Analysis was by 
intention- to- treat using linear mixed models.
results CFT reduced disability more than the group 
intervention at 6 months (mean difference, 8.65; 95% CI 
3.66 to 13.64; p=0.001), and at 12 months (mean 
difference, 7.02; 95% CI 2.24 to 11.80; p=0.004). There 
were no between- group differences observed in pain 
intensity at 6 months (mean difference, 0.76; 95% CI 
-0.02 to 1.54; p=0.056) or 12 months (mean difference, 
0.65; 95% CI -0.20 to 1.50; p=0.134).
Conclusion CFT reduced disability, but not pain, at 6 
and 12 months compared with the group- based exercise 
and education intervention. Future research should 
examine whether the greater reduction in disability 
achieved by CFT renders worthwhile differences for 
health systems and patients.
Trial registration number  ClinicalTrials. gov registry 
(NCT02145728).
InTrOduCTIOn
Low back pain (LBP) is the leading cause of 
disability worldwide, and is associated with a signif-
icant personal, social and economic burden.1–4 
International clinical guidelines5–7 encourage the 
use of non- pharmacological treatments in the form 
of physical and psychological therapies, or an inte-
gration of these therapies, to treat LBP. There is a 
vast range of physical and psychological therapies 
for LBP available, and all yield small effects on pain 
and disability.8–12
There is increasing recognition that LBP is a 
biopsychosocial disorder, which can be influ-
enced by a range of interacting factors.2 13 These 
can include pathoanatomical (eg, disc degenera-
tion),14 15 physical (eg, protective muscle guarding, 
deconditioning),16–18 psychological (eg, back 
pain beliefs, depression, fear of activity, pain self- 
efficacy),19–22 lifestyle (eg, physical inactivity, sleep 
deficits, stress)23–25 and social (eg, culture, socio-
economic status, work and family life)26 27 factors, 
which vary from individual to individual. While 
many claim we need to target these factors (where 
modifiable),13 28–30 there is debate as to whether 
more individualised interventions can provide 
better clinical outcomes than standardised interven-
tions for LBP.
Our systematic review and meta- analysis8 
showed that group- based interventions display 
similar modest effectiveness to one- to- one inter-
ventions for reducing pain and disability levels, in 
LBP and other musculoskeletal conditions. This is 
an important finding as treating people together in 
a group may be an effective use of limited resources 
for treating LBP. The counter view is that current 
one- size- fits- all physical and psychological thera-
pies are suboptimal and yield small effects because 
they lack an integrative approach and ignore the 
complex heterogeneity in LBP.29 30
A physiotherapy- led individualised interven-
tion called cognitive functional therapy (CFT), that 
targets physical, lifestyle and psychological barriers to 
recovery, was developed to help patients self- manage 
chronic low back pain (CLBP).30 Rather than adopting 
a one- size- fits- all approach, CFT provides clinicians 
with the opportunity to explore the multidimensional 
nature of LBP through the context of the individual. 
The aims of this approach are to reconceptualise pain 
from a biopsychosocial perspective while dispelling 
unhelpful beliefs, overcome barriers to functional 
participation linked to their personally relevant 
goals and adopt a healthy lifestyle. One randomised 
controlled trial (RCT)31 has tested this approach and 
it demonstrated superior effects on pain and disability 
over physiotherapist- led manual therapy and exer-
cise in people with CLBP. The superior effect on 
disability, but not pain, was maintained at the 3- year 
follow- up.32 We do not know if CFT is superior to a 
group- based exercise and education intervention.
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Figure 1 CONSORT flow diagram. CFT,cognitive functional therapy; CONSORT, Consolidated Standards of Reporting Trials
Therefore, our RCT examined whether CFT was more effec-
tive for CLBP compared with a group- based exercise and educa-
tion intervention.
MeThOds
design and setting
This trial was a two- group, pragmatic RCT in which individuals 
with CLBP were recruited from three sites in Ireland between 
May 2014 and February 2016, with follow- up at postinterven-
tion, 6 months postrandomisation and 12 months postrando-
misation. The sites were the physiotherapy departments of two 
primary care centres (Ballina Primary Care Centre and Clare-
morris Primary Care Centre) and one public hospital (Mayo 
General Hospital) that received referrals from both medical 
consultants in secondary care and primary care general practi-
tioners. A total of three physiotherapists (one in each setting) 
were chosen to deliver both interventions in this trial. The trial 
was prospectively registered on  ClinicalTrials. gov, and the study 
protocol (online supplementary file 1) has been previously 
published elsewhere.33
Participants
Patients were eligible for inclusion if they met all the following 
criteria: between 18 and 75 years of age, non- specific CLBP 
for at least 6 months duration, a score of 14% or more on the 
Oswestry Disability Index (ODI), independently mobile (with 
or without aids) to be capable of participating in a rehabilita-
tion programme, and able to speak and understand English well 
enough to complete the questionnaires independently.
Exclusion criteria were primary pain area other than the lower 
back (from T12 to buttocks), leg pain as the primary problem 
(eg, nerve root compression or disc prolapse with true radic-
ular pain/radiculopathy, lateral recess or central spinal stenosis), 
being <6 months after lumbar spine, lower limb or abdominal 
surgery, having undergone pain- relieving procedures such as 
injection- based therapy (eg, epidurals) and day case procedures 
(eg, rhizotomy) in the last 3 months, pregnancy, rheumatological/
inflammatory disease (eg, rheumatoid arthritis, ankylosing spon-
dylitis, psoriatic arthritis, lupus erythematosus, Scheuermann’s 
disease), progressive neurological disease (eg, multiple sclerosis, 
Parkinson’s disease, motor neuron disease), scoliosis (if consid-
ered the primary driver of pain), unstable cardiac conditions, red 
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Table 1 Baseline characteristics
CFT n
Group 
intervention n
Age (years) 47.0 (13.2) 106 50.6 (14.9) 96
Sex 106 100
  Male 24 (22.6%) 30 (30%)
  Female 82 (77.4) 70 (70%)
Time since diagnosis 
of LBP (months)
56 [24, 120) 104 60 (24, 156) 88
Disability (ODI) 32.05 (12.55) 106 33.51 (12.61) 100
Pain (NRS) 6.17 (2.17) 103 5.69 (2.23). 91
Risk of chronicity 
(0–100)
54.68 (13.90) 102 54.27 (15.19) 88
No of pain sites (1–9) 3.60 (1.87) 99 4.08 (2.15) 85
Stress (0–42) 15.23 (10.44) 99 6.51 (11.37) 83
Fear of physical 
activity (0–24)
14.31 (5.92) 94 16.03 (5.23) 78
Coping (0–30) 17.02 (6.02) 90 16.05 (7.07) 74
Pain self- efficacy 
(0–60)
33.76 (12.20) 99 34.42 (12.44) 83
General health 
(0–13)
9.07 (5.27) 100 9.66 (6.20) 86
Socioeconomic status 
(0–100)
60 (20.32) 99 51.75 (16.62) 80
CFT, cognitive functional therapy; LBP, low back pain; NRS, Numerical Rating 
Scale;ODI, Oswestry Disability Index.
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flag disorders like malignancy/cancer, acute traumas such as frac-
ture in the last 6 months or infection, or spinal cord compres-
sion/cauda equina syndrome.
At the initial eligibility assessment, all completed the ODI to 
ensure they met the criteria for inclusion. If eligible, and partici-
pants consented to participate after random allocation, they then 
completed the remaining sections of the questionnaire before 
their first intervention session which was within two weeks of 
the date of screening. To control for expectation bias, partici-
pants were told that the study was being performed to compare 
two interventions for CLBP, and that based on current knowl-
edge, it was not known which intervention was superior.
randomisation and masking
Simple randomisation was used. Sealed opaque envelopes were 
sent by the research team to each site. Allocation was picked 
by each participant from a sealed opaque envelope, given by 
the consulting physiotherapist, after eligibility for the study 
was established, to ensure concealed allocation. The envelope 
contained only two pieces of paper. Participants were asked to 
pick one piece of paper from the envelope. One piece of paper 
had the letter ‘C’ for class and the other, letter ‘I’ for individual-
ised CFT. Participants and physiotherapists could obviously not 
be masked to randomisation because the physiotherapists were 
administering the active intervention.
Interventions
Both interventions have been described in detail in the published 
protocol.32 We refer to the main components of each interven-
tion in this paper.
Cognitive functional therapy
All participants randomised to CFT underwent a comprehensive 
one- to- one interview and physical examination by their phys-
iotherapist, to identify any relevant multidimensional factors 
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Table 3 Intention to treat analysis—difference between group means (95% CI for difference)
Primary outcomes 6 months P value 12 months P value
Disability* 8.65 (3.66 to 13.64) 0.001 7.02 (2.24 to 11.80) 0.004
  Sensitivity analysis† 8.80 (3.56 to 14.04) 0.001 6.94 (1.91 to 11.97) 0.007
  Sensitivity analysis‡ 8.45 (3.22 to 13.69) 0.002 6.32 (1.56 to 11.08) 0.010
  Sensitivity analysis§ 8.97 (3.96 to 13.98) 0.001 6.89 (2.07 to 11.72) 0.005
  Sensitivity analysis¶ 7.62 (2.65 to 11.43) 0.003 6.54 (1.65 to 11.43) 0.009
  Sensitivity analysis** 8.84 (4.03 to 13.65) <0.001 6.56 (1.87 to 11.24) 0.006
  Per- protocol analysis†† 11.87 (6.59 to 17.14) <0.001 9.03 (3.60 to 14.45) 0.001
Effect size (95% CI) 0.67 (0.27 to 1.06) 0.55 (0.18 to 0.92)
Pain intensity* 0.76 (–0.02 to 1.54) 0.056 0.65 (–0.20 to 1.50) 0.134
  Sensitivity analysis† 0.60 (–0.22 to 1.46) 0.148 0.57 (–0.31 to 1.46) 0.204
  Sensitivity analysis‡ 0.79 (–0.07 to 1.66) 0.072 0.43 (–0.50 to 1.36) 0.358
  Sensitivity analysis§ 0.77 (–0.02 to 1.57) 0.056 0.58 (–0.28 to 1.44) 0.184
  Sensitivity analysis¶ 0.39 (–0.43 to 1.20) 0.347 0.42 (–0.46 to 1.31) 0.346
  Sensitivity analysis** 0.78 (0.02 to 1.55) 0.044 0.61 (–0.22 to 1.45) 0.150
  Per- protocol analysis†† 1.23 (0.35 to 2.11) 0.007 0.87 (–0.13 to 1.86) 0.086
Effect size (95% CI)‡‡ 0.36 (–0.03 to 0.74) 0.31 (–0.05 to 0.67)
*Mean difference (95% CI) from linear mixed models including all three time points, controlling for within group effects (random effect) and centre (fixed effect).
†Based on linear mixed models including all three time points, controlling for within group effects (random effect) and centre, age, sex and time since diagnosis (fixed effects).
‡Based on imputed data sets.
§Based on analysis of covariance (ANCOVA) of the two follow- up time points (6 months and 12 months), controlling for within group effects (random effect), and centre and 
baseline values (fixed effects).
¶Based on inverse probability of censoring weighting.
**Based on general estimating equation analysis.
††Per- protocol analysis based on linear mixed model analysis of data from those who completed all treatments, including all three time points and controlling for within group 
effects (random effect) and centre (fixed effect).
‡‡Cohen’s D computed as the mean difference relative to pooled SD of baseline scores.
Figure 2 Mean disability for CFT (individualised) versus group. *Data 
are adjusted means from the linear mixed- effects models. Error bars 
show standard errors (SE).
considered to be key drivers of their pain and disability. The 
length of the CFT intervention varied in a pragmatic manner 
based on the clinical progression of participants. There were 
then three components to the intervention: (1) cognitive compo-
nent: making sense of pain; (2) exposure with ‘control’; and (3) 
lifestyle change, which have been described in detail elsewhere.30
Group-based exercise and education intervention
The group intervention did not involve any individual inter-
view, physical examination or consideration of the patient’s 
detailed pain story. All participants in this intervention received 
a multidimensional intervention addressing the same principles 
of rehabilitation, but this was not specifically targeted to their 
individual needs or presentation. It consisted of up to six classes 
over 6–8 weeks, each lasting ~1 hour and 15 min, with up to 10 
participants in each class. There were three components to the 
intervention: (1) pain education; (2) exercise; and (3) relaxation.
Training of the physiotherapists and treatment fidelity
The training and treatment fidelity procedures are described in 
the published protocol (online supplementary file 1).32
Outcomes
The treating physiotherapists obtained the primary outcome 
measures at baseline, in advance of randomisation, as part of 
determining eligibility (ODI>14%). Outcome assessment imme-
diately postintervention was unblinded, as it was collected by 
the treating physiotherapist. For the 6 month and 12 month 
postrandomisation follow- ups, outcome measures were assessed 
by a blinded investigator who was unaware of group allocation. 
This involved posting the questionnaires to the participants. A 
blinded research assistant completed a maximum of two tele-
phone follow- ups of non- responders at 6month and 12 month 
follow- ups to remind participants to complete the questionnaires 
if possible. Returning the two primary outcomes (disability 
and pain intensity) were specifically highlighted as the most 
important to return.
Demographic characteristics such as age, sex, socioeconomic 
status and duration of LBP, were collected at baseline postrando-
misation. Socioeconomic status was measured using the Socio-
economic Condition Index.34
The primary outcomes of interest were functional disability, 
measured using the ODI (scale 0–100)35 and pain intensity over 
the last week on the 0 (no pain) to 10 (worst possible pain) 
Numerical Rating Scale (scale 0–10).36
Secondary outcome measures were fear- avoidance using the 
physical activity subscale of the Fear Avoidance Beliefs Ques-
tionnaire (scale 0–24),37 coping using the coping subscale of the 
Coping Strategies Questionnaire (scale 0–30),38 pain self- efficacy 
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Figure 3 Mean pain intensity for CFT (individualised) versus group. 
*Data are adjusted means from the linear mixed- effects models. Error 
bars show standard errors (SE).
using the Pain Self- Efficacy Questionnaire (scale 0–60),39 number 
of pain sites using the Nordic Musculoskeletal Questionnaire) 
(scale 1-9),40 risk of chronicity using the 10- item short- form 
Örebro musculoskeletal screening questionnaire (scale 0-100),41 
sleep, depression and anxiety using the relevant single item ques-
tions on the Subjective Health Complaints Inventory (scale 0–3 for 
each item),42 stress measured using the seven- item stress subscale 
of the Depression, Anxiety and Stress Scale (scale 0–42)43 and 
satisfaction using a single item question (The care that I have been 
receiving here is just about perfect; 1=strongly agree, 5=strongly 
disagree) from the Patient Satisfaction Questionnaire.44
Satisfaction was measured at postintervention only. The 
remaining outcome measures were assessed at all- time points.
statistical analysis
Descriptive statistics summarised participant characteristics using 
mean (SD), median (IQR) or number (percentage) as appropriate. 
Continuous data were assessed for skewness by visual inspec-
tion of plots and normality tests. Unadjusted mean (SD) values 
were computed for the primary and secondary continuous vari-
ables at baseline, post- treatment, 6 and 12 months. Analyses of 
the primary and secondary continuous outcome variables were 
undertaken using linear mixed models, as specified in the study 
protocol, with treatment, time, centre and treatment by time 
included as fixed effects and within- person correlation modelled 
as a random effect using an unstructured covariance structure. 
Intention- to- treat analyses used all available data at baseline, 6 
and 12 months. Mean differences at 6 and 12 months were esti-
mated by the treatment by time interaction term, with associated 
95% CIs and p values. A positive mean difference was indica-
tive of better outcome values in the individualised intervention 
(CFT). Cohen’s D effect sizes were computed as the mean differ-
ence relative to the pooled SD of baseline scores, where 0.2 was 
considered a small effect, 0.5 a moderate effect and 0.8 a large 
effect.45 Per- protocol analyses of pain and disability were under-
taken using data from participants who completed all treat-
ment sessions. Sensitivity to missing data was examined using 
multiple imputation (pooled estimates of ten imputed datasets) 
based on a multivariate normal model46 and inverse probability 
of censoring weighting (IPCW) analyses.47–49 The IPCW weights 
were obtained from a logistic regression using baseline data to 
predict follow- up response. Sensitivity to the method of anal-
ysis was examined using: (1) analyses that controlled for age, 
sex and time since diagnosis and (2) analysis of covariance anal-
yses controlling for baseline. Sensitivity to non- normality was 
examined using general estimating equation analysis with robust 
covariance estimation. The statistician was blinded to group allo-
cation, and all analyses were checked by a second statistician. χ2 
tests were used to examine group differences in satisfaction at 
post- treatment and differences in anxiety, depression and sleep 
between the intervention groups at 6 and 12 months. All data 
were analysed using IBM SPSS Statistics V.22. The 95% CIs for 
Cohen’s D effect size were computed using R package ‘psych’.50 
A 5% level of significance was used throughout the analyses.
Public and patient involvement
No members of the public or patients were involved in the 
design, conduct and interpretation of this study. Patient satisfac-
tion was measured postintervention. Qualitative interviews were 
conducted with a proportion of patients after the study.
deviations from the registered trial protocol
We made a number of deviations from our protocol.33
We removed the back beliefs questionnaire based on pilot 
testing, to reduce participant burden.
We recruited 206 participants, rather than 214 as planned, 
reflecting a power calculation of n=128 and an additional 40% 
to cover drop outs. The trial remains adequately powered. As 
the trial approached completion, it became clear that the loss to 
follow- up was closer to 30% at the 12 month follow- up.
We did not analyse the results of our postintervention 
follow- up. Due to the pragmatic nature of the CFT intervention, 
the treatment period varied, such that the CFT and group inter-
vention postintervention measures were conducted at different 
time points. Therefore, we only included the fixed time points 
of baseline, 6 and 12 months in the intention- to- treat, sensitivity 
and per- protocol analyses to prevent the potential for detection 
bias. The post- intervention scores were computed and presented 
in the descriptive analysis for completeness.
We did not conduct a responder analysis as responder analysis 
based on dichotomisation of a continuous outcome measure has 
received criticism as being potentially misleading,51 52 thus we 
present only analyses of mean differences for disability and pain 
intensity.
We analysed differences in sleep, anxiety and depression using 
χ2 tests. Non- linear mixed models did not adequately fit the 
response data from these categorical variables.
We have no detailed cost data to report. We collected costs 
data but the poor response rate and incompleteness of the 
cost questionnaires left the data quite sparse, and arguably not 
informative.
resulTs
Recruitment ran from May 2014 and the final 12 month 
follow- ups were completed in March 2017. Figure 1 shows 
the flow of participants through the trial. Of the 206 partici-
pants who were randomly assigned, 130 participants (63%) 
were followed up at postintervention, 148 participants (72%) at 
6 months and 142 participants (69%) at 12 months.
Table 1 shows the baseline characteristics of all participants. 
Measures were similar at baseline except for a difference in 
socioeconomic status that did not change significantly at 6 and 
12 months (p value for treatment by time=0.404). Participants 
were mainly female (74%), had a mean age of 48.7 years (SD 
14.1), had experienced LBP for a median of 60 months (IQR 24, 
144) and reported a mean (SD) of 3.8 (2) pain sites. No adverse 
events were reported, and 130 participants (CFT, n=66; Group, 
n=64) completed treatment. In total, the mean (SD) number of 
Protected by copyright.
 o
n
 N
ovem
ber 27, 2019 at University of Lim
erick (UL).
http://bjsm.bmj.com/
Br J Sports M
ed: first published as 10.1136/bjsports-2019-100780 on 19 October 2019. Downloaded from 
6 O'Keeffe M, et al. Br J Sports Med 2019;0:1–9. doi:10.1136/bjsports-2019-100780
Original article
Table 4 Intention- to- treat analysis of the continuous secondary outcomes
secondary outcomes 6 months P value 12 months P value
Risk of chronicity (0–100) 8.07 (2.03 to 14.11) 0.009 6.11 (0.09 to 12.12) 0.047
No of pain sites (1–9) 0.53 (–0.13 to 1.18) 0.117 0.09 (–0.49 to 0.66) 0.765
Stress (0–42) 1.36 (–2.25 to 4.98) 0.457 2.33 (–1.51 to 6.18) 0.232
Fear of physical activity
(0–24)
1.71 (–0.57 to 4.00) 0.140 1.92 (–0.32 to 4.17) 0.093
Coping (0–30) −1.91 (−3.90 to 0.08) 0.060 −2.89 (–4.96 to –0.82) 0.006
Pain self- efficacy (0–60) −6.66 (–10.93 to –2.39) 0.002 −5.99 (–10.52 to –1.46) 0.010
General health (0–13) 2.29 (0.33 to 4.24) 0.022 1.91 (0.19 to 4.01) 0.075
Socioeconomic status
(0–100)
−11.18 (–16.38 to –5.99) <0.001 −9.42 (–15.50 to –3.35) 0.003
Mean difference (95% CI) from linear mixed models including all three time points, controlling for within group effects (random effect) and location (fixed effect).
Table 5 Anxiety, depression and sleep (categorical data) scores from the Subjective Health Complaints Inventory
CFT Group intervention
none A little some severe none A little some severe P value
Anxiety
baseline
44 (45.8) 29 (30.2) 15 (15.6) 8 (8.3) 43 (50.6) 17 (20) 15 (17.6) 10 (11.8)
Anxiety
postintervention
28 (45.9) 20 (32.8) 12 (19.7) 1 (1.6) 31 (49.2) 11 (17.5) 13 (20.6) 8 (12.7)
Anxiety
6 months
33 (48.5) 18 (26.5) 12 (17.6) 5 (7.4) 28 (40.0) 17 (24.3) 20 (28.6) 5 (7.1) 0.492
Anxiety
12 months
33 (47.1) 24 (34.3) 7 (10.0) 6 (8.6) 26 (45.6) 11 (19.3) 12 (21.1) 8 (14.0) 0.112
Depression baseline 53 (54.1) 20 (20.4) 17 (17.3) 8 (8.2) 42 (49.4) 20 (23.5) 17 (20.0) 6 (7.1)
Depression
postintervention
36 (58.1) 16 (25.8) 9 (14.5) 1 (1.6) 31 (50) 13 (21) 13 (21) 5 (8.1)
Depression
6 months
37 (54.4) 17 (25.0) 10 (14.7) 4 (5.9) 30 (42.9) 18 (25.7) 18 (25.7) 4 (5.7) 0.389
Depression
12 months
42 (60) 16 (22.9) 8 (11.4) 4 (5.7) 30 (49.2) 12 (19.7) 9 (14.8) 10 (16.4) 0.203
Sleep
baseline
15 (15) 20 (20.0) 42 (42) 23 (23) 16 (18.6) 14 (16.3) 34 (39.5) 22 (25.6)
Sleep
postintervention
22 (34.4) 18 (28.1) 16 (25.0) 8 (12.5) 15 (23.4) 19 (29.7) 14 (21.9) 16 (25.0)
Sleep
6 months
21 (30.9) 22 (32.4) 17 (25.0) 8 (11.8) 19 (27.1) 16 (22.9) 19 (27.1) 16 (22.9) 0.306
Sleep
12 months
18 (25.0) 21 (29.2) 23 (31.9) 10 (13.9) 19 (31.1) 12 (19.7) 17 (27.9) 13 (21.3) 0.410
Number of participants (% of participants).
CFT, cognitive functional therapy.
individualised CFT treatments attended was 5.0 (2.7), lasting 
200.8 (102.6) minutes over 13.7 (10.9) weeks and the mean 
(SD) number of group treatments attended was 4.0 (2.2), lasting 
297.8 (162.9) minutes over 4.4 (2.4) weeks.
Primary outcomes
Table 2 shows unadjusted mean (SD) values and sample sizes at 
baseline, post- treatment, 6 months and 12 months postrandomi-
sation. Table 3 presents the results from the intention- to- treat, 
sensitivity and per- protocol analyses of treatment effects for 
disability and pain intensity at 6 and 12 months.
Disability
CFT led to greater reductions in disability compared with the 
group intervention at 6 months (mean difference, 8.65; 95% CI 
3.66 to 13.64; p=0.001), and at 12 months (mean difference, 
7.02; 95% CI 2.24 to 11.80; p=0.004). See table 2 for unad-
justed means (SDs) and figure 2 for the graph of results.
Pain
There were no significant between- group differences in pain 
intensity at either 6 months (mean difference, 0.76; 95% CI 
-0.02 to 1.54; p=0.056) or 12 months (mean difference, 0.65; 
95% CI -0.20 to 1.50; p=0.134). See table 2 for unadjusted 
means (SDs) and figure 3 for the graphs of results.
secondary outcomes
Pain- self efficacy, risk of chronicity and coping (at 12 months 
only) differed significantly between interventions at 6 month 
and 12 month follow- up in favour of CFT (see tables 2 and 
4). No significant differences were found for fear of physical 
activity, stress, anxiety, depression, sleep, number of pain sites or 
postintervention satisfaction (see tables 2 and 4–6).
dIsCussIOn
CFT led to greater reductions in disability compared with a 
group exercise and education intervention at 6 and 12 months. 
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Table 6 Postintervention satisfaction with care
CFT Group intervention
Count Column n% Count Column n%
Satisfaction 
with care
Strongly 
agree
2 3.1 8 12.3
Agree 57 89.1 40 61.5
Unsure 4 6.3 16 24.6
Disagree 1 1.6 1 1.4
Strongly 
disagree
0 0 0 0
CFT, cognitive functional therapy.
What are the new findings?
 ► For people with chronic low back pain, an individualised 
multidimensional intervention (cognitive functional therapy 
(CFT)) resulted in greater long- term improvements in 
disability, compared with a group- based exercise and 
education intervention at 6 months and 12months
 ► CFT did not lead to greater improvements in pain compared 
with a group- based exercise and education intervention at 6 
months and 12 months
how might it impact on clinical practice in the future?
 ► Cognitive functional therapy (CFT), an individualised 
multidimensional assessment and treatment approach 
involving education, graded movement exposure and lifestyle 
coaching, may be a valuable intervention for reducing 
disability related to CLBP
 ► Physiotherapists should consider delivering CFT over a group- 
based exercise and education approach for reducing disability 
related to CLBP
 ► Physiotherapists will possibly need to dedicate more time 
to learning how to deliver CFT compared to a group- based 
exercise and education approach
 ► More head to head testing of CFT and common one- to- one 
physiotherapy approaches is needed
There were, however, no differences in pain intensity between 
the interventions at 6 and 12 months.
The reduction in disability in this trial is similar to the first 
CFT clinical trial31 where it was compared with physiotherapy- 
delivered manual therapy and exercise in people with CLBP. 
However, our trial did not replicate the pain intensity reductions 
shown in the first trial. The participants in our trial had higher 
disability levels, more comorbidities and received a lower dose 
of CFT on average.
The reductions in disability in this trial for the CFT interven-
tion, yielded better effects than similar trials in this area.8 53 54 
For example, our group’s systematic review and meta- analysis8 
of 14 RCTs of one- to- one versus group exercise interventions 
for musculoskeletal conditions including LBP showed similar 
effects for both group and one- to- one interventions. CFT also 
yielded a larger effect on disability than the effect observed in 
systematic reviews and clinical trials of pharmacological and 
non- pharmacological intervention for CLBP.7–9
This trial had strengths. It was prospectively registered, and 
incorporated design features known to minimise bias such as 
concealed allocation, and an intention- to- treat analysis. The 
participants were highly representative of people with disabling 
LBP in clinical practice, compared with most LBP trials which 
have very narrow inclusion criteria.55 The same trial physio-
therapists delivered both interventions, minimising differences 
in clinician expertise and communication style confounding the 
results. The trial had a strong control intervention, which differs 
from some clinical trials which offer minimal interventions, 
usual care or waiting list as the control. The control interven-
tion was optimised from previous group interventions that were 
studies in our systematic review to better reflect the multidimen-
sional nature of pain. This pragmatic trial represented clinical 
practice as we allowed the physiotherapists in the individualised 
intervention the freedom to deliver the number of sessions in 
line with their clinical judgement and available resources.
The trial has limitations. Thirty- seven per cent of randomised 
participants did not start or complete treatment, while only 72% 
completed the 6- month follow- up, and only 69% of participants 
completed the 12- month follow- up. While this was not signifi-
cantly different between interventions, we acknowledge that 
non- adherence can lead to unmeasured bias in intention- to- treat 
results.48 We were unable to blind participants, and the nature 
of the intervention meant that we also could not mask the treat-
ment providers. The two interventions in this trial are of varying 
complexity in terms of training and delivery.
LBP is a major global challenge. The cost and disability burden 
of LBP is projected to increase over the next few decades. There 
is an effort by health authorities to reduce harmful practices 
such as inappropriate imaging, opioid prescription and surgery 
which is not required, and replace them with safer alternatives 
that are acceptable to people with LBP.2 4 Our trial provides a 
credible assessment of two safe and active approaches for CLBP. 
CFT reduced disability more than a comprehensive group 
intervention.
Future research needs to explore the reasons for this. A media-
tion study will inform whether specific secondary outcomes (eg, 
pain self- efficacy) were responsible for the changes in disability. 
Would the effects on disability yielded by CFT be considered 
worthwhile by health system leaders and individuals with 
CLBP? It is important that future research examines the cost- 
effectiveness of implementing an individualised intervention like 
CFT. This would involve examining the effect on other health-
care use (eg, opioid use, imaging, surgery, injections) and societal 
costs (effect on sick leave, return to work), as well as considering 
how practical it is to scale up the intervention considering the 
increased training and extending of traditional scope of practice 
that may be necessary for physiotherapists to implement CFT.
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